home > news > detailed info

Bruker Presents High-Value Life Science, Materials Research and Applied Market Solutions at Analytica 2022

Bruker Corporation

MUNICH, Germany - June 21, 2022:
Bruker Corporation (Nasdaq: BRKR) this week displays its high-value scientific instrumentation, software and integrated solutions for applications in materials and energy research, biopharmaceuticals, applied markets, as well as life science and translational research at Analytica 2022.

Frank H. Laukien, PhD, President and CEO of Bruker Corporation, commented: “Our differentiated high-value scientific instruments and solutions shown at Analytica 2022 demonstrate the diversity, flexibility and high performance that Bruker brings to the world of laboratory science. Bruker is committed to providing optimized technological, software, chemistry and biology solutions to enable the success of our customers. We are very pleased to introduce novel solutions that now also enable Spatial Single-Cell Metabolomics, a key new capability for in situ, multiomics single-cell biology and cancer research.”
email 40 Manning Rd, Billerica
Print this page
Send to a friend
News and Press Releases

Recipharm Invests in its Single Dose Nasal Platform Capabilities

 Recipharm, a global contract development and manufacturing organisation (CDMO), has announced that it is expanding its capabilities for its proprietary Unidose® Xtra (single dose) nasal delivery platform.
More info >>

White Papers

pAVEway™ expression system for the efficient expression of therapeutic proteins

Fujifilm Diosynth Biotechnologies

One of the major bottlenecks in the production of biopharmaceuticals is the efficient expression of therapeutic proteins in microbial or mammalian cells. The Escherichia coli pAVEway™ expression system described here has been developed to ensure high product titres and efficient scale up to GMP manufacture, whilst minimising many common issues seen in other expression systems, such as ‘leaky’ expression (expression of recombinant protein in the absence of inducer).
More info >>

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement